Strengths and limitations
T1D
This is the first study to consult healthcare professionals about the training and support needed to support a national rollout of HCL to pregnant women with T1D. The topicality and relevance of our findings have been enhanced by using a workshop at the end of the study to generate contemporary practical, implementable, and clinically relevant recommendations. A potential limitation is that our study took place within the context of a UK-based trial. Many participating centers had experience supporting insulin pump and CGM users, and some had HCL experience as a result of being involved in previous trials.Hence, some interviewees may have been technology enthusiasts, with accordingly distinctive views about HCL rollout in T1D pregnancy, specific to a UK healthcare context, where there is universal CGM access. To offer a wider perspective on how a national rollout of HCL in T1D pregnancy could be achieved, future research could explore the perspectives of healthcare professionals working in less experienced centers or who have limited or no experience of supporting HCL users. Future research could also explore the experiences of healthcare professionals who support HCL users in countries that have different healthcare structures to those in the UK.